Rigel Pharmaceuticals, Inc. (RIGL)
NASDAQ: RIGL · Real-Time Price · USD
24.31
+0.40 (1.67%)
Nov 20, 2024, 4:00 PM EST - Market closed

Rigel Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Revenue
157.37115.78115.74138.74108.6259.29
Upgrade
Revenue Growth (YoY)
21.65%0.03%-16.57%27.72%83.21%33.20%
Upgrade
Cost of Revenue
37.5831.6362.0266.326153.79
Upgrade
Gross Profit
119.7984.1553.7272.4247.635.5
Upgrade
Selling, General & Admin
110.39105.74112.4591.8976.674.59
Upgrade
Operating Expenses
110.39105.74112.4591.8976.674.59
Upgrade
Operating Income
9.4-21.59-58.73-19.48-28.97-69.09
Upgrade
Interest Expense
-7.87-6.87-3.71-4.86-1.35-0.34
Upgrade
Interest & Investment Income
2.252.270.680.050.582.53
Upgrade
EBT Excluding Unusual Items
3.78-26.19-61.75-24.29-29.74-66.89
Upgrade
Merger & Restructuring Charges
---1.32-3.52--
Upgrade
Other Unusual Items
0.11.14.510.5--
Upgrade
Pretax Income
3.88-25.09-58.57-17.31-29.74-66.89
Upgrade
Income Tax Expense
---0.61--
Upgrade
Net Income
3.88-25.09-58.57-17.91-29.74-66.89
Upgrade
Net Income to Common
3.88-25.09-58.57-17.91-29.74-66.89
Upgrade
Shares Outstanding (Basic)
181717171717
Upgrade
Shares Outstanding (Diluted)
181717171717
Upgrade
Shares Change (YoY)
1.13%0.93%1.12%1.03%0.81%4.28%
Upgrade
EPS (Basic)
0.22-1.44-3.40-1.05-1.76-4.00
Upgrade
EPS (Diluted)
0.22-1.44-3.40-1.05-1.76-4.00
Upgrade
Free Cash Flow
10.72-5.74-74.215.25-53.45-42.97
Upgrade
Free Cash Flow Per Share
0.61-0.33-4.300.31-3.17-2.57
Upgrade
Gross Margin
76.12%72.68%46.41%52.20%43.85%9.27%
Upgrade
Operating Margin
5.97%-18.65%-50.74%-14.04%-26.67%-116.53%
Upgrade
Profit Margin
2.47%-21.67%-50.61%-12.91%-27.38%-112.83%
Upgrade
Free Cash Flow Margin
6.81%-4.96%-64.12%3.78%-49.21%-72.47%
Upgrade
EBITDA
11.32-20.35-57.73-18.31-28.27-68.41
Upgrade
EBITDA Margin
7.19%-17.58%-49.88%-13.20%-26.02%-115.38%
Upgrade
D&A For EBITDA
1.921.2411.160.710.68
Upgrade
EBIT
9.4-21.59-58.73-19.48-28.97-69.09
Upgrade
EBIT Margin
5.97%-18.65%-50.74%-14.04%-26.67%-116.53%
Upgrade
Revenue as Reported
157.47116.88120.24149.24108.6259.29
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.